相关实验视频
Updated: Nov 30, 2025

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory
Published on: February 28, 2013
在初级和二级预防环境中控制风险因素和心血管事件风险
Alison K Wright1,2, Milton Fabian Suarez-Ortegon3,4, Stephanie H Read5,6,7
1Division of Diabetes, Endocrinology and Gastroenterology, School of Medical Sciences, University of Manchester, United Kingdom (A.K.W., M.K.R.).
与对照组相比,最佳控制的2型糖尿病 (T2D) 将心血管疾病 (CVD) 的风险增加21%. 患有T2D和没有心脏脏疾病的个体从心血管疾病风险因素干预中获得显著的潜在益处.
科学领域:
- 心脏病学
- 内分泌学
- 公共卫生
背景情况:
- 心血管疾病是2型糖尿病的主要并发症.
- 风险因素控制对T2D心脏病风险的影响,特别是与同时存在的心脏脏病,需要进一步研究.
研究的目的:
- 在T2D患者中研究风险因素控制程度与心血管疾病风险之间的关联.
- 确定心脏脏疾病是否会改变这种关联.
主要方法:
- 使用CPRD GOLD和SCI-糖尿病数据集 (2006-2015) 的回顾性队列研究.
- 包括101,749名T2D患者和378,938名对照患者.
- 根据优化风险因素 (吸烟,胆固醇,甘油三,HbA1c,静脉血压) 的数量评估心血管疾病风险.
主要成果:
- 具有最佳风险因子控制的T2D患者心血管疾病风险比对照患者高21% (aHR,1. 21).
- 在T2D患者中,高风险因素增加了心脏病的风险1. 09,但在没有心脏病的患者中增加了1. 96.
- 没有心脏脏疾病的患者年轻,风险因素控制较低,药物处方较少.
结论:
- 与对照组相比,对T2D风险因素的最佳管理与较高的心血管疾病风险有关.
- 患有T2D且没有心脏脏疾病的个体可能从加强心血管疾病风险因素干预中显著受益.
更多相关视频
07:22Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
Published on: March 7, 2025
04:36Author Spotlight: Understanding Retinal Vessel Resilience and Disease Progression
Published on: January 12, 2024
相关概念视频
Diabetes Mellitus: Type 2 and Gestational
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Coronary Artery Disease IV: Preventive Measures
Coronary Artery Disease I: Introduction